News from NYU Langone Health
The 4 Essential Ingredients For “New CEO” Success. (Big Think)
(10/7) Robert I. Grossman, MD, former CEO of NYU Langone Health and dean of NYU Grossman School of Medicine, who is currently executive vice president to the Board of Trustees, emphasizes the importance of CEOs focusing on the institution rather than personal ego, stating, “I see a lot of CEOs who are very much about themselves,” adding, “They have a lot of ego, and some arrogance… and they view the job as a destination, not a journey.”
FDA Approval Of Intravesical Mitomycin In NMIBC Follows ODAC Debate On Need For Randomized Data. (OncLive)
(10/7) The FDA’s approval of intravesical mitomycin (UGN-102; Zusduri) for low-grade, intermediate-risk, non–muscle-invasive bladder cancer offers a nonsurgical treatment alternative, marking a shift from the traditional surgical approach of transurethral resection of bladder tumors, according to William C. Huang, MD, vice chair, clinical affairs, professor, Departments of Urology and Radiology, chief, urology service, Perlmutter Cancer Center, who said, “It’s going to be a paradigm shift for many patients, from something that’s primarily been surgical to something that is nonsurgical and chemoablative,” with potential benefits for patients who experience regular recurrences or are medically frail.
Eye Drop Allows Nearsighted Persons To Read Without Glasses. (KTBY-TV Anchorage (AK))
(10/7) A new type of eye drop, which shrinks the pupil to improve near vision, has shown promising results, allowing hundreds of patients overseas to read small print within an hour, with some maintaining this improvement for over a year; Robert C. Cykiert, MD, clinical associate professor, Department of Ophthalmology, said this kind of treatment could be life changing for people who dislike wearing or losing their reading glasses, but cautioned that more research is needed to assess long-term safety and effectiveness, and most insurance plans do not cover these drops.
Healthy Diet Offers Pain Relief, Not From Weight Loss Alone. (Medscape)
(10/7)* A study in the European Journal of Nutrition found that a 3-month weight-loss dietary intervention reduced chronic musculoskeletal pain scores by half among patients with overweight or obesity, with Meera K. Kirpekar, MD, clinical assistant professor, Department of Anesthesiology, Perioperative Care, and Pain Medicine, saying, “A diet high in saturated or processed foods, red meat, high-fat dairy products, and high-sugar foods can alter the body’s gut microbiome and immune system, leading to inflammation in the body, which worsens chronic pain.”
CT Imaging Use In US Emergency Departments Nearly Doubles Over The Past Decade, Study Finds. (Applied Radiology (UK))
(UK) (10/2) A study in Radiology, using Medicare data from 2013 to 2023, reveals a dramatic rise in CT scan use in U.S. emergency departments, driven by more scans per visit rather than increased patient numbers, with CT utilization per 100 beneficiaries nearly doubling, and per 100 ED encounters rising 133.5%, according to Andrew B. Rosenkrantz, MD, professor, Departments of Urology, and Radiology, section chief, Body Imaging, Department of Radiology, and Ryan Cummings, MD, resident, Department of Radiology, and Ryan Cummings, MD, radiology resident, who wrote, “The pronounced increase in CT utilization per ED encounter may reflect an evolving role of CT in ED care delivery; for example, when prompt CT ordering is used to expedite patient turnover,” highlighting concerns about resource strain and the need for further research on imaging efficiency and sustainability.
Study: Noninvasive Brain Stimulation Reduces Cannabis Use In MS. (LifeTechnology)
(10/7) A study by NYU Langone Health has revealed that noninvasive brain stimulation may effectively reduce cannabis use in women with multiple sclerosis (MS), offering a promising advancement in MS treatment; the research involved delivering weak electrical currents to specific brain regions to modulate neural activity, resulting in a notable decrease in cannabis consumption among participants receiving the intervention compared to a control group, thereby highlighting the potential of neurostimulation techniques in addressing substance use disorders and enhancing patient outcomes.
4 New ASCs In New York. (Becker's ASC Review)
(10/7) Since September, NYU Langone Health has opened a new ambulatory practice in Commack, N.Y., while Albany Med Health System has initiated an expansion at Greene Medical Arts in Catskill, N.Y., to include a same-day surgery center; additionally, NewYork-Presbyterian has launched NewYork-Presbyterian The One, an outpatient center in White Plains, N.Y., and two plastic surgeons, Oren Tepper, MD, and Evan Garfein, MD, have introduced Greenwich Street Surgical, a membership-based surgical facility in New York City.
